Vytrus Biotech, a CataloniaBio member, has raised more than €600,000 in a capital increase it closed on 29 October. This investment came through a crowdequity campaign on the Capital Cell platform.

Specifically, the biotechnology firm raised 110% of its initial goal of €550,000 and has become one of the first companies in Spain to raise over half a million euros through this type of campaign.

The investment will go towards boosting the company’s industrial growth and research lines, as well as helping prepare the company to go public next year.

Vytrus has distribution deals in more than 50 countries and six of its own products on the market, all with multiple active ingredients from plant stem cells. These products include applications for protecting skin from the sun, whitening skin, protecting sensitive skin, boosting hair growth and preventing ageing.

More information is available on the Vytrus Biotech website.

Photo: Albert Jané and Òscar Expósito, founders of Vytrus Biotech - © Vytrus Biotech